Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage.

Kuramatsu JB, Mauer C, Kiphuth IC, Lücking H, Kloska SP, Köhrmann M, Huttner HB.

Neurosurgery. 2012 Feb;70(2):342-50; discussion 350. doi: 10.1227/NEU.0b013e3182311266.

PMID:
21826030
2.

Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.

Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J.

Neurology. 2004 Sep 28;63(6):1059-64.

PMID:
15452298
3.

Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.

Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T.

Stroke. 2006 Aug;37(8):2165-7. Epub 2006 Jun 29.

4.

Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage.

Moussouttas M, Malhotra R, Fernandez L, Maltenfort M, Holowecki M, Delgado J, Lawson N, Badjatia N.

Neurocrit Care. 2010 Feb;12(1):24-9. doi: 10.1007/s12028-009-9290-0.

PMID:
19844810
5.

Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?

Stead LG, Jain A, Bellolio MF, Odufuye AO, Dhillon RK, Manivannan V, Gilmore RM, Rabinstein AA, Chandra R, Serrano LA, Yerragondu N, Palamari B, Decker WW.

Clin Neurol Neurosurg. 2010 May;112(4):275-81. doi: 10.1016/j.clineuro.2009.12.002. Epub 2009 Dec 29.

PMID:
20042270
6.

Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.

Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE; CHANT Investigators.

Neurology. 2009 Apr 21;72(16):1397-402. doi: 10.1212/01.wnl.0000342709.31341.88. Epub 2009 Jan 7.

7.

Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage.

Yildiz OK, Arsava EM, Akpinar E, Topcuoglu MA.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):760-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.003. Epub 2011 Jun 17.

PMID:
21683617
8.

Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.

Toyoda K, Yasaka M, Nagata K, Nagao T, Gotoh J, Sakamoto T, Uchiyama S, Minematsu K; Bleeding with Antithrombotic Therapy Study Group.

Cerebrovasc Dis. 2009;27(2):151-9. doi: 10.1159/000177924. Epub 2008 Nov 28.

PMID:
19039219
9.

Predictors of outcome in warfarin-related intracerebral hemorrhage.

Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA.

Arch Neurol. 2008 Oct;65(10):1320-5. doi: 10.1001/archneur.65.10.1320.

PMID:
18852345
10.

Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage.

Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Piñeiro S, Pagola J, Hernandez-Guillamon M, Ibarra B, Romero F, Alvarez-Sabin J, Montaner J, Molina CA.

Neurology. 2011 Oct 25;77(17):1599-604. doi: 10.1212/WNL.0b013e3182343387. Epub 2011 Oct 12.

PMID:
21998314
11.

Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.

Roquer J, Rodríguez Campello A, Gomis M, Ois A, Puente V, Munteis E.

J Neurol. 2005 Apr;252(4):412-6. Epub 2005 Mar 3.

PMID:
15739042
12.

Prior statin use reduces mortality in intracerebral hemorrhage.

Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR.

Neurocrit Care. 2008;8(1):6-12.

PMID:
17701108
13.

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.

Arch Neurol. 2008 May;65(5):607-11. doi: 10.1001/archneur.65.5.noc70077. Epub 2008 Mar 10.

PMID:
18332238
14.

Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage.

Gebel JM Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP.

Stroke. 2002 Nov;33(11):2636-41.

15.

Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage.

Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Pagola J, Piñeiro S, Ibarra B, Meler P, Maisterra O, Romero F, Alvarez-Sabin J, Molina CA.

Stroke. 2011 Sep;42(9):2447-52. doi: 10.1161/STROKEAHA.110.609461. Epub 2011 Jul 28.

16.

C-reactive-protein levels associated with infection predict short- and long-term outcome after supratentorial intracerebral hemorrhage.

Diedler J, Sykora M, Hahn P, Rupp A, Rocco A, Herweh C, Steiner T.

Cerebrovasc Dis. 2009;27(3):272-9. doi: 10.1159/000199465. Epub 2009 Feb 6.

PMID:
19202332
17.

Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.

Lacut K, Le Gal G, Seizeur R, Prat G, Mottier D, Oger E.

Fundam Clin Pharmacol. 2007 Jun;21(3):327-33.

PMID:
17521302
18.

Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage.

Stead LG, Jain A, Bellolio MF, Odufuye A, Gilmore RM, Rabinstein A, Chandra R, Dhillon R, Manivannan V, Serrano LA, Yerragondu N, Palamari B, Jain M, Decker WW.

Neurocrit Care. 2010 Aug;13(1):67-74. doi: 10.1007/s12028-010-9355-0.

PMID:
20390379
19.
20.

Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.

Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T.

Neurology. 2005 Oct 11;65(7):1000-4.

PMID:
16217049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk